Related Experiment Video
Updated: Jan 27, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
Published on: April 23, 2021
Origin-destination flows in chemotherapy for breast cancer in Brazil: implications for pharmaceutical services
Mário Jorge Sobreira da Silva1, Enirtes Caetano Prates Melo2, Claudia Garcia Serpa Osorio-de-Castro3
1Coordenação de Ensino, Instituto Nacional de Câncer José Alencar Gomes da Silva. R. Marquês de Pombal 125, Centro. 20230-130 Rio de Janeiro RJ Brasil. mjsobreira@yahoo.com.br.
Abstract:
This study maps and analyzes patient flows for breast cancer chemotherapy in order to identify the potential implications for organization of pharmaceutical services in the cancer care network. An ecological study design sought to correlate the place of residence with place of care for breast cancer patients. All chemotherapy procedures financed by Brazil's Unified Health System (SUS) and performed from January to December 2013 were included. Flows were mapped using TerraView® software. A total of 1 347 803 outpatient chemotherapy procedures were delivered by 243 cancer care units located in 156 municipalities. Seventeen cities concentrated approximately 50.0 % of the procedures. A total of 8 538 origin-destination flows were generated and 49.2% of procedures were performed in services located outside the municipality in which the patient resided. Context challenges, related to inequality of access to chemotherapy and hindrances in planning and management of pharmaceutical services, were discussed.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

